Johnson & Johnson Free Cash Flow 2007–2025
Johnson & Johnson reported $19.70B of free cash flow for fiscal 2025. That was 0.7% lower than fiscal 2024. Compared with fiscal 2019, the change was -1.1%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $19.70B | -0.7% |
| FY 2024 | $19.84B | +8.7% |
| FY 2023 | $18.25B | +6.2% |
| FY 2022 | $17.18B | -13.0% |
| FY 2022 | $19.76B | -2.1% |
| FY 2021 | $20.19B | +1.4% |
| FY 2019 | $19.92B | +7.5% |
| FY 2018 | $18.53B | +4.2% |
| FY 2017 | $17.78B | +14.4% |
| FY 2017 | $15.54B | -3.5% |
| FY 2016 | $16.11B | +7.4% |
| FY 2014 | $15.00B | +8.5% |
| FY 2013 | $13.82B | +10.9% |
| FY 2012 | $12.46B | +9.3% |
| FY 2012 | $11.40B | -18.5% |
| FY 2011 | $14.00B | -1.4% |
| FY 2010 | $14.21B | +19.3% |
| FY 2008 | $11.91B | -1.4% |
| FY 2007 | $12.08B | — |
Source: Johnson & Johnson SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open JNJ 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Johnson & Johnson reported $19.70B of free cash flow for fiscal 2025. That was 0.7% lower than fiscal 2024. Compared with fiscal 2019, the change was -1.1%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Johnson & Johnson
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeJohnson & Johnson — frequently asked questions
What is Johnson & Johnson's free cash flow?
Johnson & Johnson (JNJ) reported free cash flow of $19.70B for fiscal year 2025, per its SEC filings.
How has Johnson & Johnson's free cash flow changed over time?
Between fiscal 2007 and 2025, JNJ's free cash flow grew at roughly 2.8% per year (compound annual rate), from $12.08B to $19.70B.
Where does this data come from?
Figures are computed from Johnson & Johnson's official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.